Aenitis Technologies

Aenitis will be participating in ISCT Dublin 2026

Marie — Thu, 23 Apr 2026 11:28:53 +0000

Emmanuel Vincent, our CEO, will be attending the ISCT Annual Meeting in Dublin, Ireland, from 6 to 9 May 2026 at the Convention Centre Dublin. At ISCT, Aenitis will highlight its Acoustic Cell Handling platform and its Modular Type Package (MTP) approach, designed to facilitate the integration of acoustic unit operations into existing bioprocess workflows. A pioneer in acoustic-based […]

Source

Publication – Acoustic Beads: A novel method for cell sorting…

Marie — Tue, 02 Dec 2025 09:37:36 +0000

Rare cell sorting is a critical step in bioprocessing as cells are often exposed to various environmental factors that can affect their growth, differentiation, and overall behaviour. Acoustophoresis, a non-invasive technique using acoustic radiation forces, offers a gentler and more precise alternative to conventional cell manipulation methods. In a millifluidic channel, acoustic radiation forces act […]

Source

Bracco and Aenitis Join Forces to Develop “Acoustic Beads” for…

Paul Saltet — Wed, 08 Jan 2025 15:33:00 +0000

Access the full Press Release: English Version / French Version Paris, France, January 8, 2025 – Aenitis Technologies, a leader in acoustofluidic innovations, has entered a Memorandum of Understanding (MOU) with Bracco Imaging, a global pharmaceutical company leader that develops, manufactures and markets contrast agents and associated solutions for medical innovative healthcare solutions. This strategic partnership is set […]

Source

Aenitis will be participating in the JP Morgan 43rd Annual…

Paul Saltet — Thu, 02 Jan 2025 09:49:00 +0000

Emmanuel Vincent, our CEO, will be attending the JP Morgan 43rd Annual Healthcare Conference in San Francisco, CA, USA, from 13 to 16 January. Aenitis, a pioneer in acoustic-based cell manipulation, is revolutionizing bioproduction with its non-invasive, scalable acoustofluidic technology. This innovation enables precise, sterile, and cost-effective cell processing for research, clinical, and industrial applications. […]

Source

Aenitis Secures Strategic Funding to Redefine Bioproduction with Sole-In-Class Acoustofluidic…

Paul Saltet — Tue, 12 Nov 2024 15:08:00 +0000

Access the full Press Release: English Version / French Version ● Aenitis is set to transform the bioproduction industry by addressing theincreasing need for scalable, cost-effective, and highly precise cell processingtechnologies.● Mitis™, the flagship product of its unique Acoustofluidic Technology, is alreadyused across various applications, from research to clinical and industrial scales,including cell sorting, isolation, concentration, and washing.● Funding round led by the […]

Source

Aenitis will be participating in the Matinale Deeptech on November

Paul Saltet — Tue, 12 Nov 2024 13:49:00 +0000

Emmanuel Vincent, our CEO, will participate in the POC Media – Matinale Deeptech: “Les Nouveaux Acteurs des Biothérapies,” organized by the Agence de l’Innovation en Santé and Polepharma at the Paris Santé Cancer Campus on November 7th. Aenitis, a pioneer in acoustic-based cell manipulation, is revolutionizing bioproduction with its non-invasive, scalable acoustofluidic technology. This innovation […]

Source

Aenitis has been featured in Les Echos

Paul Saltet — Thu, 24 Oct 2024 18:45:00 +0000

We are delighted to announce that Aenitis has been featured in Les Echos following our successful fundraising to redefine bioproduction with our sole-in-class acoustofluidic technology!Thanks to Paul Molga for this enriching interview. Headline: « Aenitis raises 6.5 million euros for its cell sorting machines by levitation »Read the full article on Les Echos: https://www.lesechos.fr/pme-regions/innovateurs/aenitis-attire-65-millions-deuros-pour-ses-machines-de-tri-cellulaire-par-levitation-2124332 Together, we set to […]

Source

Aenitis has been featured in Biotech et Finances

Paul Saltet — Thu, 24 Oct 2024 18:42:00 +0000

We are pleased to share that Aenitis has been featured in Biotech et Finances! Our CEO, Emmanuel Vincent, spoke with Guillaume Mollaret about our recent successful fundraising to redefine bioproduction with our unique acoustofluidic technology. During the discussion, Emmanuel Vincent also highlighted the addition of two new members to our Strategic Board and the significant […]

Source

Publication Elsevier-Feasibility of an acoustophoresis-based system for a high-throughput cell…

Paul Saltet — Fri, 24 Nov 2023 19:00:00 +0000

These last decades have seen the emergence and development of cell-based therapies, notably those based on mesenchymal stromal cells (MSCs). The advancement of these promising treatments requires increasing the throughput of processed cell for industrialization in order to reduce production costs. Among the various bioproduction challenges, downstream processing, including medium exchange, cell washing, cell harvesting and volume reduction, remains a […]

Source

Poster ISCT 2023-Novel method to enhance T-lymphocyte viral transduction by…

Paul Saltet — Fri, 24 Nov 2023 18:54:00 +0000

Gene editing using lentiviral vectors has become a compelling and safe method in cellular therapy specifically for T-cells through the expression of a chimeric antigen receptor. However, the efficiency of the gene transfer to the T-cells has remained a burden. Another limitation of this very approach is that these viral vectors are hard to provide, […]

Source